期刊文献+

恶性肿瘤患者高凝状态与血栓形成的临床研究 被引量:20

Clinical research on high coagulation state and thrombosis in patients with cancer
原文传递
导出
摘要 目的探讨恶性肿瘤患者高凝状态与血栓形成的临床表现、危险因素和治疗情况,以期提高临床治疗水平。方法回顾性分析2008年1月至2012年1月间收治的393例恶性肿瘤患者,对其中40例出现高凝状态或血栓形成患者的临床表现、危险因素和治疗等情况进行总结。结果恶性肿瘤患者高凝状态与血栓形成临床症状以患肢肿痛、髂窝股三角区疼痛和压痛、皮温升高为主;实验室检查以D-2聚体、凝血酶原时间、活化部分凝血酶时间升高为主;超声表现为实质性回声,CT表现为动脉充盈缺损。高凝状态与血检形成的危险因素有置管、升白治疗、卧床和手术(P<0.05),其形成时间以治疗后2个月内为主,占全部的77.5%。临床治疗总有效率为85.0%。结论高凝状态与血栓形成与恶性肿瘤患者的治疗等有关,抗凝治疗后预后较好。 Objective To investigate the hypercoagulable state in patients with cancer and thrombosis in clinical manifestations, risk factors and treatment in order to improve the level of clinical treatment. Methods A retrospective analysis in January 2008 -2012 in January 393 cases of cancer, 40 cases of them appear to have a hypercoagulable state or thrombosis in patients from the clinical manifestations, risk factors and treatment summary of the situation. Results Cancer patients hypereoagulable state and thrombosis symptoms were limb pain, femoral triangle ifiac fossa pain and tenderness, skin temperature based; laboratory tests to D-2 dimer, prothrombin time, activated partial thromboplastin time increased mainly ultrasound showed substantial echo, CT showed arterial filling defect; risk factors were catheter, elevated white blood cell therapy, in bed and surgery (P 〈0. 05) ; formation time in two months, accounting for 77.5% of total; clinical total effective rate was 85.0%. Conclusion The hypercoagulable state of cancer patients and pa- tients with thrombosis treatment related to anticoagulant therapy better prognosis.
出处 《中国肿瘤临床与康复》 2014年第5期542-544,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 癌症 高凝状态 血栓形成 临床分析 Cancer Hypercoagulable state Thrombosis Clinical analysis
  • 相关文献

参考文献9

二级参考文献118

  • 1张晓香,张香玉,刘娜.深静脉置管导管阻塞18例[J].实用医药杂志,2004,21(11):1009-1009. 被引量:24
  • 2王惠杰,张湘茹.恶性肿瘤与血栓性疾病[J].癌症进展,2006,4(1):39-46. 被引量:73
  • 3吉晓滨.血小板与肿瘤细胞的相互作用[J].国外医学(耳鼻咽喉科学分册),1997,21(1):14-18. 被引量:8
  • 4杨惠洁.癌转移与宿主血液循环变化[J].中华医学杂志,1990,70(6):306-306.
  • 5陆风翔.内科临床处方手册[M].南京:江苏科学技术出版社,2002.406-410.
  • 6Boing AF,Rossi TF.Temporal trend in and spatial distributinn of lung cancer mortality in Brazil Between 1979 and 2004:magnitude,regional patterns,and gender-related differences.J Bras Pneumol,2007,33:544-551.
  • 7Prandoni P,Lensing AW,Piccioli A,et al.Recurrent venous thromboembolism andbleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.Blood,2002,100:3484-3488.
  • 8Biota JW,Doggen CJ,Osanto S,et al.Malignancies,prothrombotic mutations,and the risk of venous thrombosis.JAMA,2005,293:715-722.
  • 9Prandoni P,Falanga A,Piccioli A.Cancer and venous thromboembolism.Lancet Oncol,2005,6:401-410.
  • 10Bugge TH,Xiao Q,Kombrinck KW,et al.Fatal embryonic bleeding events in mice lacking tissue factor,the cellassociated initiator of blood coagulation.Proc Nail Acad Sci U S A,1996,93:6258-6263.

共引文献130

同被引文献204

引证文献20

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部